P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB-VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL.

Autor: Sabina Kersting, Mark-David Levin, Julie Dubois, Yvette van Norden, Johan Dobber, Yvonne Jauw, Anne-Marie van der Kevie-Kersemaekers, Clemens Mellink, Caspar Da Cunha-Bang, Leonie Van Desr Burg, Doreen Te Raa, Fransien de Boer, Jolanda Droogendijk, Cecile Idink, Koen De Heer, Marten Nijziel, Lidwine Tick, Inge Ludwig, Mathijs Silbermann, Aart Beeker, Mar Bellido, Ludo Evers, Gerben Zwezerijnen, Josée Zijlstra, Marcel Kap, Carsten Niemann, Arnon Kater

Publikováno v: HemaSphere, Vol 7, p e797861a (2023)

Externí odkaz: https://doaj.org/article/def1784e57be41248dd5770881eba9b2

P1523: IMMUNOGENICITY OF THE 13-VALENT PNEUMOCOCCAL CONJUGATED VACCINE FOLLOWED BY THE 23-VALENT POLYSACCHARIDE VACCINE IN CHRONIC LYMPHOCYTIC LEUKEMIA

Autor: Sabine Haggenburg, Hannah Garcia Garrido, Iris Kant, Hanneke van der Straaten, Fransien De Boer, Sabina Kersting, Djamila Issa, Doreen Te Raa, Hein Visser, Arnon Kater, Abraham Goorhuis, Koen De Heer

Publikováno v: HemaSphere, Vol 7, p e8157636 (2023)

Externí odkaz: https://doaj.org/article/4f9c8d0f1af449eaaf7ebbb0a4c4f5a5

Diagnosis, treatment and supportive management of chronic lymphocytic leukemia

Autor: Doreen G Te, Raa, Lina, van der Straten, Michel, van Gelder, Sabina, Kersting, Mark-David, Levin, Rogier, Mous, Hanneke M, van der Straaten, Marten R, Nijziel, Ellen, van der Spek, Eduardus F M, Posthuma, Hein P J, Visser, Marjolein, van der Klift, Koen, de Heer, Mar, Bellido, Jeanette K, Doorduijn, Anke H W, Bruns, Reinier A P, Raijmakers, Arnon P, Kater

Publikováno v: HOVON CLL study group 2022, ' Diagnosis, treatment and supportive management of chronic lymphocytic leukemia : recommendations of the Dutch HOVON CLL working group ', Leukemia and Lymphoma, vol. 63, no. 10, pp. 2276-2289 . https://doi.org/10.1080/10428194.2022.2084731

Management of patients with chronic lymphocytic leukemia (CLL) is changing due to considerable advances in the therapeutic armamentarium, and new therapies will possibly continue to emerge in the near future. Therefore, the CLL working group of the D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc5ffe46d9de15522c014f7cbb5f7ef
https://hdl.handle.net/11370/29686129-bbf3-41c9-8726-fd23f290d6e6

Supplementary Tables 1-3, Figures 1-4 from Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas

Autor: Arnon P. Kater, Raluca Verona, Carel J.M. van Noesel, Eric Eldering, Homer C. Adams, Niels W.C.J. van de Donk, Christie P.M. Verkleij, Marcel Spaargaren, Koen de Heer, Lotte W.H.G. van Mil, An Ngo, Fleur S. Peters, Renate de Boer, Joanne M. Rietveld, Anne W.J. Martens

Supplementary Table 1. CLL Patient characteristics. Supplementary Table 2. Healthy donor characteristics. Supplementary Table 3. MM patient characteristics. Supplementary Figure 1. γ-secretase inhibition increases BCMA levels but does not affect via

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc8d79d31bbb2bed19c309d64008198
https://doi.org/10.1158/2767-9764.22544582

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

Autor: Ymke van der Pol, Steven Wang, Norbert Moldovan, A.Vera de Jonge, Esther E.E. Drees, Margaretha Roemer, Bauke Ylstra, Marcel Nijland, Marjolein W.M. Van Der Poel, Koen de Heer, Clara Klerk, Rozemarijn van Rijn, Rob Fijnheer, Vibeke K.J. Vergote, Aart Beeker, Laurens Nieuwenhuizen, Rogier Mous, Joost S.P. Vermaat, D. Michiel Pegtel, Martine E.D. Chamuleau, Florent Mouliere

Publikováno v: Blood. 140:3529-3531

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e82560e389bf4f3a3a84e755a7d35689
https://doi.org/10.1182/blood-2022-168668